Inogen Ownership
| INGN Stock | USD 10.05 0.10 1.01% |
Shares in Circulation | First Issued 2012-12-31 | Previous Quarter 23.6 M | Current Value 23.8 M | Avarage Shares Outstanding 21.4 M | Quarterly Volatility 2.1 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Inogen |
Inogen Stock Ownership Analysis
About 97.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.33. Some equities with similar Price to Book (P/B) outperform the market in the long run. Inogen Inc recorded a loss per share of 2.25. The entity had not issued any dividends in recent years. Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. Inogen operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1021 people. To learn more about Inogen Inc call Nabil Shabshab at 805 562 0500 or check out https://www.inogen.com.Besides selling stocks to institutional investors, Inogen also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Inogen's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Inogen's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Inogen Quarterly Liabilities And Stockholders Equity |
|
Inogen Insider Trades History
Only 1.78% of Inogen Inc are currently held by insiders. Unlike Inogen's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Inogen's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Inogen's insider trades
Inogen Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Inogen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Inogen Inc backward and forwards among themselves. Inogen's institutional investor refers to the entity that pools money to purchase Inogen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-06-30 | 548.3 K | New York State Common Retirement Fund | 2024-06-30 | 506.7 K | State Street Corp | 2024-06-30 | 497 K | Meros Investment Management, Lp | 2024-06-30 | 397.2 K | Dimensional Fund Advisors, Inc. | 2024-06-30 | 387.7 K | Renaissance Technologies Corp | 2024-06-30 | 354.6 K | Federated Hermes Inc | 2024-06-30 | 344.7 K | Jacobs Levy Equity Management, Inc. | 2024-06-30 | 310.4 K | Jane Street Group Llc | 2024-06-30 | 301.4 K | Divisadero Street Capital Management, Lp | 2024-06-30 | 2.3 M | Camber Capital Management Llc | 2024-06-30 | 2 M |
Inogen Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Inogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Inogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Inogen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Inogen Outstanding Bonds
Inogen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Inogen Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Inogen bonds can be classified according to their maturity, which is the date when Inogen Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US45782BAD64 Corp BondUS45782BAD64 | View | |
| Installed Building Products Corp BondUS45780RAA95 | View |
Inogen Corporate Filings
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 7th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F3 | 24th of July 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Pair Trading with Inogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inogen will appreciate offsetting losses from the drop in the long position's value.Moving together with Inogen Stock
Moving against Inogen Stock
| 0.78 | BSX | Boston Scientific Corp | PairCorr |
| 0.67 | VMD | Viemed Healthcare | PairCorr |
| 0.65 | DRIO | DarioHealth Corp | PairCorr |
| 0.6 | FIGS | Figs Inc | PairCorr |
| 0.42 | CVS | CVS Health Corp | PairCorr |
The ability to find closely correlated positions to Inogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inogen Inc to buy it.
The correlation of Inogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.873 | Earnings Share (2.25) | Revenue Per Share 14.095 | Quarterly Revenue Growth 0.058 | Return On Assets (0.1) |
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.